ABBV

Without Drugs, Johnson & Johnson Has Nothing (JNJ)

Johnson & Johnson (JNJ) showed investors its smallest earnings beat in nearly a year. The upside: The dividend on JNJ stock is well-covered. More 

Gilead Sciences, Inc. Is More Than an HCV Play (GILD)

Gilead Sciences (GILD) stock is a bargain at these prices. Traders just have yet to see the glass as half full. More 

24 Biotechnology Stocks to Buy Now

24 Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More 

4 Stocks to Buy for Big October Dividend Hikes (CTAS, CHDN, TXN, ABBV)

Looking for consistent, double-digit dividend hikes? Your job is getting harder. We'll make it easier with these dividend stocks to buy More 

FDA Issues Warning on Hepatitis C Drugs

The Food and Drug Administration (FDA) has issued a warning surrounding several Hepatitis C drugs such as Sovaldi, Harvoni and Gilead Sciences. More 

79 Trades to Make Before Earnings Season

It pays to stay on top of the latest profit opportunities, and today's Portfolio Grader updates provide a roadmap for investors More 

25 Biotechnology Stocks to Buy Now

25 Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More